Clinical trial
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
NCT04769167 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
- Lead sponsor
- Washington University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2021
- Completion date
- December 5, 2023
- Enrollment
- 114 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease, diabetes, diabetes mellitus, diabetes mellitus, type 1, diabetes mellitus, type 2, enterovirus, enterovirus infections, heart defects, congenital, heart diseases, pregnancy complications, pregnancy in diabetic, prenatal, prenatal infection, viremia, virus diseases